{
  "retracted": false,
  "timestamp": 1481846400000,
  "updates": [
    {
      "timestamp": 1581600218746,
      "identifier": {
        "doi": "10.1074/jbc.a116.717736"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1074/jbc.m116.717736"
  },
  "publisher": "American Society for Biochemistry & Molecular Biology (ASBMB)",
  "title": "Proprotein convertase subtilisin/Kexin type 9 (PCSK9) single domain antibodies are potent inhibitors of low density lipoprotein receptor degradation."
}
